Updated May 25 at 10:25am
Biotechnology
33 results total, viewing 31 - 33
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
The Defense Threat Reduction Agency is investing $5.2 million for the development of a new type of vaccine against Q fever, and a local company is involved in the effort. more
ProThera Biologics has appointed Denice M. Spero as president and chief business officer. more
« Prev | 1 | 2 | 3 | 4